Dr Michel Dorval is Full Professor at the Faculty of Pharmacy. He holds a Master’s degree in Psychology (1984) and a Doctorate in Epidemiology (1997) from Université Laval, complemented by postdoctoral training from Dana-Farber Cancer Institute (Harvard Medical School) thanks to a Terry Fox Fellowship from the National Cancer Institute of Canada. From 1999 to 2011, he constantly held research career awards (Junior I, Junior II, Senior) from the Fonds de la recherche du Québec-Santé (FRQS).

Since the beginning of his career, Dr. Dorval has used a variety of methodological approaches, both quantitative and qualitative, to better understand the impact of breast cancer at all stages of the disease on patients, women at risk and their families. He has always demonstrated a commitment to improving health services through active involvement in knowledge translation. For example, the results of his work led to the creation in 2012 of Centre ROSE (Ressources en Oncogénétique pour le Soutien et l’Éducation), which he co-founded with his colleague Dr. Jocelyne Chiquette. The mission of Centre ROSE was to inform and support people with hereditary cancer risk, and to provide evidence-based tools to health professionals. Center ROSE has received several awards, including the Hommage aux Innovations Sociales from Université Laval (2014), the Prix d’Excellence Innovation dans la Communauté from the Quebec Breast Cancer Foundation (2016) and the Prix Promotion de la Santé et Prévention from the Direction générale de cancérologie du Québec (2016). In 2015, Centre ROSE evolved into Réseau ROSE (www.reseaurose.ca) by adding satellites in various regions of Quebec. As a continuation of the Réseau ROSE, work is underway since 2020 under the aegis of RUISSS-UL to create the Réseau en Oncogénétique de l’Est du Québec.

In addition to his work on breast cancer, Dr. Dorval has always been interested in palliative care. He is a member of the research team at the Maison Michel-Sarrazin and of the Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL) since its founding. He is currently leading an interdisciplinary and intersectoral team whose work aims to 1) evaluate the social and professional acceptability of psilocybin-assisted therapy to relieve existential distress at the end of life, 2) identify issues to be considered for access to this innovative therapy and 3) propose recommendations establishing guidelines for the use of psilocybin for therapeutic purposes in the Quebec medico-legal context.

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
J0-21
Québec, Québec
Canada G1S 4L8
77 entries « 1 of 8 »

Espinoza-Moya ME, Guertin JR, Floret A, Dorval M, Lapointe J, Chiquette J, Bouchard K, Nabi H, Laberge M

Mapping inter-professional collaboration in oncogenetics: Results from a scoping review

Journal Article

Crit Rev Oncol Hematol, 199 , 2024.

Abstract | Links:

Corbeil O, Anderson É, Béchard L, Desmeules C, Huot-Lavoie M, Bachand L, Brodeur S, Carmichael PH, Jacques C, Solmi M, Giroux I, Dorval M, Demers MF, Roy MA

Problem gambling in psychotic disorders: A systematic review and meta-analysis of prevalence

Journal Article

Acta Psychiatr Scand, 149 (6), 2024.

Abstract | Links:

Mc Brearty C, Bisaillon L, Dorval M, Nabi H, Desbiens C, Lemieux J, Théberge V, Baghdadli A, Lauzier S, Savard J

Disruptions in Cancer Care Due to the COVID-19 Pandemic and Fear of Cancer Recurrence in Women with Breast Cancer: A Mixed-Methods Study

Journal Article

Curr Oncol, 31 (2), 2024.

Abstract | Links:

Pomey MP, Paquette J, Nelea MI, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Vachon MF, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M

Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors

Journal Article

BMC Health Serv Res, 24 (1), 2024.

Abstract | Links:

Plourde L, Chang SL, Farzin H, Gagnon P, Hébert J, Foxman R, Deschamps P, Provost F, Masse-Grenier M, Stephan JF, Cheung K, Joly Y, Fallu JS, Dorval M,

Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey

Journal Article

Palliat Med, 38 (2), 2024.

Abstract | Links:

Savard J, Filion C, Brearty CM, Caplette-Gingras A, Chiquette J, Dorval M

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

Journal Article

Cancer Med, 13 (1), 2024.

Abstract | Links:

Walker MJ, Blackmore KM, Chang A, Lambert-Côté L, Turgeon A, Antoniou AC, Bell KA, Broeders MJM, Brooks JD, Carver T, Chiquette J, Després P, Easton DF, Eisen A, Eloy L, Evans DG, Fienberg S, Joly Y, Kim RH, Kim SJ, Knoppers BM, Lofters AK, Nabi H, Paquette JS, Pashayan N, Sheppard AJ, Stockley TL, Dorval M, Simard J, Chiarelli AM

Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities

Journal Article

Cancers (Basel), 16 (11), 2024.

Abstract | Links:

Pomey MP, Nelea MI, Normandin L, Vialaron C, Bouchard K, Côté MA, Duarte MAR, Ghadiri DP, Fortin I, Charpentier D, Lavoie-Tremblay M, Fernandez N, Boivin A, Dorval M, Desforges M, Régis C, Ganache I, Bélanger L, Rosberger Z, Danino MA, Pelletier JF, Vu TTT, de Guise M

An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress

Journal Article

BMC Cancer, 23 (1), 2023.

Abstract | Links:

Dauge A, Joly Y, Kaiser B, Chiquette J, Lapointe J, Simard J, Dorval M, Nabi H

General Medical Practitioners Acting as Geneticists, a Risky Business?

Journal Article

28 (1), 2023.

Abstract | Links:

Pomey MP, Paquette J, Iliescu-Nelea M, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M

Accompanying patients in clinical oncology teams: Reported activities and perceived effects

Journal Article

Health Expect, 26 (2), 2023.

Abstract | Links:

77 entries « 1 of 8 »
Signaler des ajouts ou des modifications

Active projects

  • Bourse de recrutement pour étudia.nt.e(s} gradué.e(s), from 2024-04-01 to 2026-08-31
  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes : une nouvelle voie vers le rétablissement, from 2020-03-01 to 2024-12-31
  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes: considérations post pandémiques, motivations et trajectoires., from 2023-07-01 to 2026-06-30
  • Développement d’un outil d’aide à la décision à l'intention des personnes considérant la thérapie assistée par la psilocybine pour soulager la détresse existentielle, from 2023-06-01 to 2025-03-31
  • Entre jeux vidéo et jeux de hasard et d'argent: quand les jeunes atteints de troubles psychotiques franchissent la ligne, from 2024-03-01 to 2025-02-28
  • La psilocybine pour traiter la détresse existentielle en fin de vie, from 2024-06-20 to 2025-06-30
  • Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), from 2017-11-01 to 2025-09-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2025-03-31
  • What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2025-03-31

Recently finished projects

  • Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
  • FGR - La psilocybine pour soulager la détresse existentielle en fin de vie : Audace, acceptabilité et accès, from 2021-11-12 to 2022-11-11
  • La psilocybine pour soulager la détresse existentielle en fin de vie: Audace, acceptabilité et accès, from 2022-04-01 to 2024-03-31
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2023-10-27
Data provided by the Université Laval research projects registery